Literature DB >> 7731259

Cortical petechial hemorrhage, leukoencephalopathy, and subacute dementia associated with seizures due to cerebral amyloid angiopathy.

P L Silbert1, J D Bartleson, G M Miller, J E Parisi, M S Goldman, F B Meyer.   

Abstract

Although cerebral amyloid angiopathy is a well-known cause of cerebral lobar hemorrhage, subacute dementia, seizures, and acute encephalopathy without lobar hemorrhage are infrequently recognized as manifestations of this disease. In this report, we describe a case of cerebral amyloid angiopathy in a 74-year-old woman who had subacute progressive dementia and a superimposed rapid acute neurologic deterioration associated with seizures and the presence of cerebral edema on computed tomographic scans and leukoencephalopathy and cortical petechial hemorrhages on magnetic resonance imaging. A diagnosis of cerebral amyloid angiopathy in conjunction with small cortical infarcts and petechial hemorrhages was confirmed by antemortem biopsy. This clinical and radiologic picture is being increasingly recognized as characteristic of cerebral amyloid angiopathy.

Entities:  

Mesh:

Year:  1995        PMID: 7731259     DOI: 10.4065/70.5.477

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  3 in total

1.  [Sporadic cerebral amyloid angiopathy with ischemic leukoencephalopathy and microbleeds. Cause for a rapidly progressive dementia syndrome].

Authors:  J Katchanov; G Bohner; M Könneker; U Kopp; K Izadpanah; E Larmann; R Klingebiel; F van Landeghem; F Masuhr; R Zschenderlein
Journal:  Nervenarzt       Date:  2005-10       Impact factor: 1.214

2.  Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis.

Authors:  Carlo Salvarani; Gene G Hunder; Jonathan M Morris; Robert D Brown; Teresa Christianson; Caterina Giannini
Journal:  Neurology       Date:  2013-09-27       Impact factor: 9.910

Review 3.  Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment.

Authors:  Raoul P Kloppenborg; Edo Richard; Marieke E S Sprengers; Dirk Troost; Piet Eikelenboom; Paul J Nederkoorn
Journal:  J Neuroinflammation       Date:  2010-03-09       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.